On 2025-05-08, Rapport Therapeutics, Inc. (RAPP) announced earnings per share of $-0.68 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.77.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.87 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.77 | $-0.68 |
| 2025-03-11 | 2024-12-31 | $-0.62 | $-0.57 |
| 2024-11-07 | 2024-09-30 | $-0.57 | $-0.50 |
| 2024-08-08 | 2024-06-30 | $-0.68 | $-1.70 |
| 2024-06-03 | 2024-03-31 | -- | $-11.07 |